Preclinical toxicity and efficacy testing of RiVax, a recombinant protein vaccine against ricin (Q47606597)

4 February 2018

title

Preclinical toxicity and efficacy testing of RiVax, a recombinant protein vaccine against ricin (English)

1 reference

4 February 2018

1 reference

5

Ellen S Vitetta

1 reference

4 February 2018

Joan E Smallshaw

1

object named as

Joan E Smallshaw

1 reference

4 February 2018

author name string

James A Richardson

2

1 reference

4 February 2018

Seth Pincus

3

1 reference

4 February 2018

John Schindler

4

1 reference

4 February 2018

language of work or name

English

0 references

publication date

1 September 2005

1 reference

4 February 2018

published in

Vaccine

1 reference

4 February 2018

volume

23

1 reference

4 February 2018

issue

39

1 reference

4 February 2018

page(s)

4775-4784

1 reference

4 February 2018

Ricin: structure, mode of action, and some current applications.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.037

Entry of lethal doses of abrin, ricin and modeccin into the cytosol of HeLa cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.037

Georgi Markov--death in a pellet.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.037

Identification and characterization of a monoclonal antibody that neutralizes ricin toxicity in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.037

Modification of the carbohydrate in ricin with metaperiodate-cyanoborohydride mixtures. Effects on toxicity and in vivo distribution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.037

Ricin A-chain structural determinant for binding substrate analogues: a molecular dynamics simulation analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.037

Analysis of several key active site residues of ricin A chain by mutagenesis and X-ray crystallography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.037

Site-directed mutagenesis of ricin A-chain and implications for the mechanism of action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.037

Evidence for a structural motif in toxins and interleukin-2 that may be responsible for binding to endothelial cells and initiating vascular leak syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.037

A novel recombinant vaccine which protects mice against ricin intoxication.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.037

Cytotoxicity of a recombinant ricin-A-chain fusion protein containing a proteolytically-cleavable spacer sequence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.037

Point mutations in the hydrophobic C-terminal region of ricin A chain indicate that Pro250 plays a key role in membrane translocation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.037

Evaluation of ricin A-chain immunotoxins directed against human T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.037

Combined effects of interferon alpha and interleukin 2 on the induction of a vascular leak syndrome in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.037

Immunological characteristics associated with the protective efficacy of antibodies to ricin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.037

Finding a new vaccine in the ricin protein fold

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.04.037

10.1016/J.VACCINE.2005.04.037

7 January 2021

Identifiers

DOI

1 reference

4 February 2018

PubMed ID

15961194

1 reference

4 February 2018